{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:23:16Z","timestamp":1788481396601,"version":"build-2803163510"},"reference-count":405,"publisher":"FapUNIFESP (SciELO)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"abstract":"<jats:p>ABSTRACT Significant progress has been obtained since the III Brazilian Consensus Conference on H. pylori infection held in 2012, in Bento Gon\u00e7alves, Brazil, and justify a fourth meeting to establish updated guidelines on the current management of H. pylori infection. Therefore, the N\u00facleo Brasileiro para Estudo do Helicobacter pylori e Microbiota (NBEHPM), association linked to Brazilian Federation of Gastroenterology (FBG) held its fourth meeting again in Bento Gon\u00e7alves, RS, Brazil, on August 25-27, 2017. Twenty-six delegates, including gastroenterologists, endoscopists, and pathologists from the five regions of Brazil as well as one international guest from the United States, participated in the meeting. The participants were invited based on their knowledge and contribution to the study of H. pylori infection. The meeting sought to review different aspects of treatment for infection; establish a correlation between infection, dyspepsia, intestinal microbiota changes, and other disorders with a special emphasis on gastric cancer; and reassess the epidemiological and diagnostic aspects of H. pylori infection. Participants were allocated into four groups as follows: 1) Epidemiology and Diagnosis, 2) Dyspepsia, intestinal microbiota and other afections, 3) Gastric Cancer, and, 4) Treatment. Before the consensus meeting, participants received a topic to be discussed and prepared a document containing a recent literature review and statements that should be discussed and eventually modified during the face-to-face meeting. All statements were evaluated in two rounds of voting. Initially, each participant discussed the document and statements with his group for possible modifications and voting. Subsequently, during a second voting in a plenary session in the presence of all participants, the statements were voted upon and eventually modified. The participants could vote using five alternatives: 1) strongly agree; 2) partially agree; 3) undecided; 4) disagree; and 5) strongly disagree. The adopted consensus index was that 80% of the participants responded that they strongly or partially agreed with each statement. The recommendations reported are intended to provide the most current and relevant evidences to management of H. pylori infection in adult population in Brazil.<\/jats:p>","DOI":"10.1590\/s0004-2803.201800000-20","type":"journal-article","created":{"date-parts":[[2018,4,14]],"date-time":"2018-04-14T13:25:55Z","timestamp":1523712355000},"page":"97-121","source":"Crossref","is-referenced-by-count":82,"title":["IVTH BRAZILIAN CONSENSUS CONFERENCE ON HELICOBACTER PYLORI INFECTION"],"prefix":"10.1590","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8721-7696","authenticated-orcid":false,"given":"Luiz Gonzaga Vaz","family":"COELHO","sequence":"first","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Ramalho","family":"MARINHO","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Ci\u00eancias da Sa\u00fade de Alagoas, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"GENTA","sequence":"additional","affiliation":[{"name":"Miraca Life Sciences, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laercio Ten\u00f3rio","family":"RIBEIRO","sequence":"additional","affiliation":[{"name":"Hospital Universit\u00e1rio Prof. Alberto Antunes, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria do Carmo Friche","family":"PASSOS","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Schlioma","family":"ZATERKA","sequence":"additional","affiliation":[{"name":"Universidade de Campinas, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Pimentel","family":"ASSUMP\u00c7\u00c3O","sequence":"additional","affiliation":[{"name":"Universidade Federal do Par\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo Jos\u00e9 A","family":"BARBOSA","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"BARBUTI","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia Liban\u00eas","family":"BRAGA","sequence":"additional","affiliation":[{"name":"Universidade Federal do Cear\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helenice","family":"BREYER","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aloisio","family":"CARVALHAES","sequence":"additional","affiliation":[{"name":"Hospital S\u00e3o Lucas, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9cio","family":"CHINZON","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"CURY","sequence":"additional","affiliation":[{"name":"Cl\u00ednica SCOPE, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerson","family":"DOMINGUES","sequence":"additional","affiliation":[{"name":"Universidade Estadual do Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Luiz","family":"JORGE","sequence":"additional","affiliation":[{"name":"Consult\u00f3rio M\u00e9dico, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismael","family":"MAGUILNIK","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederico Passos","family":"MARINHO","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim Prado de","family":"MORAES-FILHO","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Miguel Luz","family":"PARENTE","sequence":"additional","affiliation":[{"name":"Universidade Federal do Piau\u00ed, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso Mirra de","family":"PAULA-E-SILVA","sequence":"additional","affiliation":[{"name":"Consult\u00f3rio M\u00e9dico, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"PEDRAZZOLI-J\u00daNIOR","sequence":"additional","affiliation":[{"name":"Universidade S\u00e3o Francisco, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Fl\u00e1via Passos","family":"RAMOS","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich","family":"SEIDLER","sequence":"additional","affiliation":[{"name":"Universidade Cat\u00f3lica de Bras\u00edlia, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Nonato","family":"SPINELLI","sequence":"additional","affiliation":[{"name":"Endov\u00eddeo, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Vitor","family":"ZIR","sequence":"additional","affiliation":[{"name":"Consult\u00f3rio M\u00e9dico, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2018,4,16]]},"reference":[{"key":"ref1","first-page":"53","article-title":"Consenso Nacional sobre H. pylori e afec\u00e7\u00f5es associadas","volume":"15","author":"Coelho LGV","year":"1996","journal-title":"GED Gastroenterol Endosc Dig"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1590\/S0004-28032005000200012","article-title":"II Consenso Brasileiro sobre H. pylori","volume":"42","author":"Coelho LG","year":"2005","journal-title":"Arq Gastroenterol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1590\/S0004-28032013005000001","article-title":"3rd Brazilian Consensus on H. pylori","volume":"50","author":"Coelho LG","year":"2013","journal-title":"Arq Gastroenterol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/gutjnl-2015-309252","article-title":"Kyoto global consensus report on H. pylori gastritis","volume":"64","author":"Sugano K","year":"2015","journal-title":"Gut"},{"key":"ref5","series-title":"Projeto Diretrizes","year":"2017"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.dld.2008.02.035","article-title":"Natural history of H. pylori infection","volume":"40","author":"Correa P","year":"2008","journal-title":"Dig Liver Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bpg.2006.10.005","article-title":"Epidemiology of H. pylori infection","volume":"21","author":"Malaty HM","year":"2007","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2036.2002.0160s1003.x","article-title":"Review article: natural history and epidemiology of H. pylori infection","volume":"16","author":"Go MF","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4269\/ajtmh.15-0297","article-title":"Serologic evidence for fecal-oral transmission of H. pylori","volume":"94","author":"Bui D","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1590\/S0004-28032004000400008","article-title":"Evidence of mother-child transmission of H. pylori infection","volume":"41","author":"Escobar ML","year":"2004","journal-title":"Arq Gastroenterol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1017\/S0950268814003938","article-title":"Environmental risk factors associated with H. pylori seroprevalence in the United States: a cross-sectional analysis of NHANES data","volume":"143","author":"Krueger WS","year":"2015","journal-title":"Epidemiol Infect"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/hel.12199","article-title":"The prevalence of H. pylori remains high in African American and Hispanic veterans","volume":"20","author":"Nguyen T","year":"2015","journal-title":"Helicobacter"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/hel.12217","article-title":"Intrafamilial, preferentially mother-to-child and intraspousal, H. pylori infection in Japan determined by mutilocus sequence typing and random amplified polymorphic DNA fingerprinting","volume":"20","author":"Yokota S","year":"2015","journal-title":"Helicobacter"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1099\/jmm.0.080507-0","article-title":"Analysis of intra-familial transmission of H. pylori in Japanese families","volume":"64","author":"Osaki T","year":"2015","journal-title":"J Med Microbiol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jare.2013.07.007","article-title":"Contaminated water as a source of H. pylori infection: A review","volume":"6","author":"Aziz RK","year":"2015","journal-title":"J Advanced Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"17618","DOI":"10.3748\/wjg.v20.i46.17618","article-title":"Epidemiology of H. pylori infection among the healthy population in Iran and countries of the Eastern Mediterranean Region: A systematic review of prevalence and risk factors","volume":"20","author":"Eshraghian A","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref17","first-page":"93","article-title":"Non-human reservois of H. pylori","volume":"9","author":"Fox JG","year":"1995","journal-title":"Aliment Pharmacol Ther"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1365-2036.2000.00095.x","article-title":"Review article: have we found the source of H. pylori?","volume":"14","author":"M\u00e8graud F","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/REVEH.2009.24.1.1","article-title":"H. pylori in water sources: a global environmental health concern","volume":"24","author":"Dube C","year":"2009","journal-title":"Rev Environ Health"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/oxfordjournals.epirev.a018040","article-title":"H. pylori: epidemiology and routes of transmission","volume":"22","author":"Brown LM","year":"2000","journal-title":"Epidemiol Rev"},{"key":"ref21","first-page":"489","article-title":"H. pylori infection in the child population in Spain: prevalence, related factors and influence on growth","volume":"63","author":"Leandro Liberato SV","year":"2005","journal-title":"An Pediatr (Barc)"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/01.ede.0000201257.31155.a0","article-title":"The mother as source of H. pylori infection","volume":"17","author":"Weyermann M","year":"2006","journal-title":"Epidemiology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/ajg.2008.61","article-title":"Acquisition of H. pylori infection in early childhood: independent contributions of infected mothers, fathers, and siblings","volume":"104","author":"Weyermann M","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1523-5378.2011.00894.x","article-title":"Natural history of H. pylori infection in childhood: eight-year follow-up cohort study in an urban community in northeast of Brazil","volume":"17","author":"Queiroz DM","year":"2012","journal-title":"Helicobacter"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4269\/ajtmh.2006.75.509","article-title":"H. pylori infection in children of low and high socioeconomic status in northeastern Brazil","volume":"75","author":"Parente JM","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.trstmh.2005.08.001","article-title":"History of breastfeeding and H. pylori infection in children: results of a community-based study from northeastern Brazil","volume":"100","author":"Rodrigues MN","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/tropej\/fmm051","article-title":"H. pylori colonization among children up to 6 years: results of a community-based study from Northeastern Brazil","volume":"53","author":"Braga AB","year":"2007","journal-title":"J Trop Pediatr"},{"key":"ref28","first-page":"298","article-title":"H. pylori in children and association with CagA strains in mother-child transmission in the Brazilian amazon region","volume":"42","author":"Cart\u00e1genes VD","year":"2009","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0035-9203(03)90063-0","article-title":"Prevalence and risk factors associated with H. pylori infection in native populations from Brazilian western amazon","volume":"97","author":"Almeida Cunha RP","year":"2003","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1523-5378.2007.00474.x","article-title":"Factors Related to H. pylori Prevalence in an adult population in Brazil","volume":"12","author":"Zaterka S","year":"2007","journal-title":"Helicobacter"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0140-6736(87)92145-3","article-title":"Campylobacter pylori detected noninvasively by the 13C-urea breath test","volume":"1","author":"Graham DY","year":"1987","journal-title":"Lancet"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.1365-2036.2004.02203.x","article-title":"Review article: 13C-urea breath test in the diagnosis of H. pylori infection: a critical review","volume":"20","author":"Gisbert JP","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"ref33","first-page":"5","article-title":"Efficacy and cost-effectiveness of the 13C-urea breath test as the primary diagnostic investigation for the detection of Helicobacter pylori infection compared to invasive and non-invasive diagnostic tests","author":"Nocon M","year":"2009","journal-title":"GMS Health Technol Assess"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3748\/wjg.v21.i4.1305","article-title":"Accuracy of urea breath test in H. pylori infection: meta-analysis","volume":"21","author":"Ferwana M","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"No. 19","key":"ref35","first-page":"1","article-title":"Carbon-13 urea breath test for H. pylori infection in patients with uninvestigated ulcer-like dyspepsia: an evidence-based analysis","volume":"Vol. 13","author":"Ling D","year":"2013","journal-title":"Ontario Health Technology Assessment Series"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1590\/S0100-879X1999001200007","article-title":"Application of isotope-selective non-dispersive infrared spectrometry for the evaluation of the 13C-urea breath test: comparison with three concordant methods","volume":"32","author":"Coelho LG","year":"1999","journal-title":"Braz J Med Biol Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00005176-200207000-00010","article-title":"13C-urea breath test with infrared spectroscopy for diagnosing H. pylori infection in children and adolescents","volume":"35","author":"Kawakami E","year":"2002","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1523-5378.2011.00863.x","article-title":"13C-urea breath test for the diagnosis of H. pylori infection in children: a systematic review and meta-analysis","volume":"16","author":"Leal YA","year":"2011","journal-title":"Helicobacter"},{"key":"ref39","first-page":"2330","article-title":"Guidelines for the management of H. pylori infection. Ad Hoc Committee on practice Parameters of the American College of Gastroenterology","volume":"93","author":"Howden CW","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection-the Maastricht V\/Florence Consensus Report","volume":"66","author":"Malfertheiner P","year":"2017","journal-title":"Gut"},{"key":"ref41","first-page":"92","article-title":"Performance of 13C-urea breath test using substrate synthesized in Brazil","volume":"21","author":"Coelho LG","year":"2016","journal-title":"Helicobacter"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3109\/00365529709007677","article-title":"13C-urea breath test in H. pylori diagnosis and eradication. Correlation to histology, origin of \u2018false\u2019 results, and influence of food intake","volume":"32","author":"Epple HJ","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"ref43","first-page":"1865","article-title":"Minimum analysis requirements for the detection of H. pylori infection by the 13C-urea breath test","volume":"88","author":"Klein PD","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"ref44","first-page":"224","article-title":"13C-urea breath test to con\ufb01rm eradication of H. pylori","volume":"90","author":"Slomianski A","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/gut.45.2008.i18","article-title":"The 13C urea breath test in the diagnosis of H. pylori infection","volume":"45","author":"Savarino V","year":"1999","journal-title":"Gut"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/gut.36.6.845","article-title":"High H. pylori numbers are associated with low eradication rate after triple therapy","volume":"36","author":"Moshkowitz M","year":"1995","journal-title":"Gut"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-2036.11.s1.3.x","article-title":"Non-endoscopic tests in the diagnosis of H. pylori infection","volume":"11","author":"Atherton JC","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s10620-006-9590-6","article-title":"Elevated 13C urea breath test values females infected with H. pylori","volume":"52","author":"Shmuely H","year":"2007","journal-title":"Dig Dis Sci"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1365-2362.2010.02467.x","article-title":"Age and gender differences in urea breath test results","volume":"41","author":"Zevit N","year":"2011","journal-title":"Eur J Clin Invest"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4291\/wjgp.v3.i3.80","article-title":"Gender-associated differences in urea breath test for H. pylori infection referrals and results among dyspeptic patients","volume":"3","author":"Moshkowitz M","year":"2012","journal-title":"World J Gastrointest Pathophysiol"},{"key":"ref51","first-page":"92","article-title":"13C-urea breath test values: a large database study focusing at gender differences","volume":"17","author":"Marinho FP","year":"2012","journal-title":"Helicobacter"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1128\/CMR.00033-06","article-title":"Helicobacter pylori detection and antimicrobial susceptibility testing","volume":"20","author":"Megraud F","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1111\/j.1572-0241.2006.00668.x","article-title":"Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta-analysis","volume":"101","author":"Gisbert JP","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00535-009-0069-z","article-title":"Comparison of a monoclonal with a polyclonal antibody-based enzyme immunoassay stool test in diagnosing H. pylori infection after eradication therapy","volume":"44","author":"Deguchi R","year":"2009","journal-title":"J Gastroenterol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.clinre.2014.02.001","article-title":"Accuracy of stool antigen test for the diagnosis of H. pylori infection in children: a meta-analysis","volume":"38","author":"Zhou X","year":"2014","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/hel.12053","article-title":"Comparison of the diagnostic accuracy of five different stool antigen tests for the diagnosis of H. pylori infection","volume":"18","author":"Korkmaz H","year":"2013","journal-title":"Helicobacter"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0140-6736(98)08103-3","article-title":"Diagnosis of H. pylori infection with a new non-invasive antigen-based assay. HpSA European study group","volume":"354","author":"Vaira D","year":"1999","journal-title":"Lancet"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-136-4-200202190-00007","article-title":"The stool antigen test for detection of H. pylori after eradication therapy","volume":"136","author":"Vaira D","year":"2002","journal-title":"Ann Intern Med"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1523-5378.2010.00757.x","article-title":"Accuracy of monoclonal stool tests for determining cure of H. pylori infection after treatment","volume":"15","author":"Calvet X","year":"2010","journal-title":"Helicobacter"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.clinbiochem.2017.05.005","article-title":"Evaluation of diagnostic accuracy of two rapid stool antigen tests using an immunochromatographic assay to detect H. pylori","volume":"50","author":"da Silva-Etto JMK","year":"2017","journal-title":"Clin Biochem"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/MPG.0b013e3181ac6770","article-title":"Validation of a monoclonal stool antigen test for diagnosing Helicobacter pylori infection in young children","volume":"50","author":"Raguza D","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1128\/JCM.01752-13","article-title":"Helicobacter pylori infection in infants and toddlers in South America: concordance between [13C]urea breath test and monoclonal H. pylori stool antigen test","volume":"51","author":"Queiroz DM","year":"2013","journal-title":"J Clin Microbiol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"11221","DOI":"10.3748\/wjg.v21.i40.11221","article-title":"Diagnosis of Helicobacter pylori infection: Current options and developments","volume":"21","author":"Wang YK","year":"2015","journal-title":"World J Gastroentrol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/2229-516X.174003","article-title":"The diagnostic accuracy of rapid urease biopsy test compared to histopathology in implementing \u201ctest and treat\u201d policy for Helicobacter pylori","volume":"6","author":"Roy AD","year":"2016","journal-title":"Int J Appl Basic Med Res"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"392","DOI":"10.5946\/ce.2012.45.4.392","article-title":"United rapid urease test is superior than separate test in detecting Helicobacter pylori at the gastric antrum and body specimens","volume":"45","author":"Moon SW","year":"2012","journal-title":"Clin Endosc"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1177\/2050640615573374","article-title":"A combined antral and corpus rapid urease testing protocol can increase diagnostic accuracy despite a low prevalence of Helicobacter pylori infection in patients undergoing routine gastroscopy","volume":"3","author":"Parihar V","year":"2015","journal-title":"UEG Journal"},{"key":"ref67","first-page":"5265","article-title":"Evaluation of invasive and noninvasive methods for the diagnosis of Helicobacter pylori infection","volume":"17","author":"Cosgun Y","year":"2016","journal-title":"Asian Pacific J Cancer Prev"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1097\/PAS.0000000000000097","article-title":"Appropriate use of special stains for identifying Helicobacter pylori","volume":"37","author":"Batts KP","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"ref69","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12404","article-title":"Diagnosis of Helicobacter pylori infection","volume":"22","author":"Bess\u00e8de E","year":"2017","journal-title":"Helicobacter"},{"key":"ref70","series-title":"The Kyoto Classification of Gastritis","author":"Haruma K","year":"2010"},{"key":"ref71","series-title":"Helicobacter pylori","first-page":"157\u2010167","volume-title":"Endoscopic findings of H. pylori infection","author":"Kato M","year":"2016"},{"key":"ref72","article-title":"Linked color imaging improves endoscopic diagnosis of active Helicobacter pylori infection","volume":"4","author":"Dohi O","year":"2016","journal-title":"Endosc Int Open"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"508\u201018","DOI":"10.1111\/den.12031","article-title":"Diagnosis of Helicobacter pylori infection in gastric mucosa by endoscopic features: a multicenter prospective study","volume":"25","author":"Kato T","year":"2013","journal-title":"Dig Endosc"},{"key":"ref74","article-title":"Diagnostic performance of magnifying endoscopy for Helicobacter pylori infection: a meta-analysis","volume":"11","author":"Qi Q","year":"2016","journal-title":"PLoS One"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"2099\u2010103","DOI":"10.7314\/APJCP.2016.17.4.2099","article-title":"Improved detection of Helicobacter pylori infection and premalignant gastric mucosa using conventional white light source gastroscopy","volume":"17","author":"Matrakool L","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0016-5107(00)70412-3","article-title":"A prospective evaluation of new rapid urease tests before and after eradication treatment of H. pylori, in comparison with histology, culture and 13C-urea breath test","volume":"51","author":"Nishikawa K","year":"2000","journal-title":"Gastrointest Endosc"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s005350170044","article-title":"A 13C-urea breath test in children with H. pylori infection: assessment of eradication therapy and follow-up after treatment","volume":"36","author":"Yoshimura N","year":"2001","journal-title":"J Gastroenterol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1572-0241.2003.07426.x","article-title":"Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors","volume":"98","author":"Graham DY","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1572-0241.2004.30162.x","article-title":"Effect of proton pump inhibitors and antacid therapy on 13C-urea breath tests and stool test for H. pylori infection","volume":"5","author":"Gatta L","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.diagmicrobio.2008.07.006","article-title":"A rapid lateral flow stool antigen immunosssay and 14C-urea breath test for diagnosis and eradication of H. pylori infection in children","volume":"62","author":"Kulo\u011flu Z","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000087045","article-title":"Eradication of H. pylori can be accurately confirmed 14 days after termination of triple therapy using a high-dose citric acid-based 13C-urea breath test","volume":"71","author":"Shirin H","year":"2005","journal-title":"Digestion"},{"key":"ref82","first-page":"751","article-title":"Accuracy of a new monoclonal stool antigen test in post-eradication assessment of H. pylori infection: Comparison with polyclonal stool antigen test and urea breath test","volume":"37","author":"Manesa G","year":"2005","journal-title":"Dig Dis Sci"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"5878","DOI":"10.3748\/wjg.v11.i37.5878","article-title":"Comparison of a monoclonal antigen stool test (Hp StAR) with the 13C-urea breath test (UBT) in monitoring H. pylori eradication therapy","volume":"11","author":"Perri F","year":"2005","journal-title":"World J Gastroenterol"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1083-4389.2004.00235.x","article-title":"Stool antigen test for the diagnosis of H. pylori infection: A systematic review","volume":"9","author":"Gisbert JP","year":"2004","journal-title":"Helicobacter"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1756283X11432492","article-title":"The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy","volume":"5","author":"M\u00e9graud F","year":"2012","journal-title":"Ther Adv Gastroenterol"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.3748\/wjg.v23.i16.2854","article-title":"Importance of antimicrobial susceptibility testing for the management of eradication in Helicobacter pylori infection","volume":"23","author":"Arslan N","year":"2017","journal-title":"World J Gastroenterol"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/QCO.0000000000000396","article-title":"Antibiotic resistance in Helicobacter pylori","volume":"30","author":"Alba C","year":"2017","journal-title":"Curr Opin Infect Dis"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2169\/internalmedicine.49.3031","article-title":"Is antimicrobial susceptibility testing necessary before first-line treatment for Helicobacter pylori infection? Meta-analysis of randomized controlled trials","volume":"49","author":"Wenzhen Y","year":"2010","journal-title":"Inter Med"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/hel.12231","article-title":"Antimicrobial susceptibility-guided therapy versus empirical concomitant therapy for eradication of Helicobacter pylori in a region with high rate of clarithromycin resistance","volume":"21","author":"Cosme A","year":"2015","journal-title":"Helicobacter"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1093\/jac\/dkv155","article-title":"Systematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment for Helicobacter pylori infection","volume":"70","author":"L\u00f3pez-G\u00f3ngora S","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1038\/ajg.2014.222","article-title":"Pretreatment antimicrobial susceptibility-guided vs. clarithromycin-based triple therapy for Helicobacter pylori eradication in a region with high rates of multiple drug resistance","volume":"109","author":"Park CS","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"ref92","first-page":"9299","article-title":"H. pylori infection - recent developments in diagnosis","volume":"20","author":"Lopes AI","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10620-015-3877-4","article-title":"H. pylori infection: diagnostic strategies in primary diagnosis and after therapy","volume":"61","author":"Atkinson NSS","year":"2015","journal-title":"Dig Dis Sci"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/hel.12030","article-title":"Comparative evaluation of 29 commercial H. pylori serological kits","volume":"18","author":"Burucoa C","year":"2013","journal-title":"Helicobacter"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1128\/JCM.35.2.427-432.1997","article-title":"Immunoblot assay for serodiagnosis of H. pylori infections","volume":"35","author":"Nilsson I","year":"1997","journal-title":"J Clin Microbiol"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/1471-2180-9-193","article-title":"Geographic distribution of methyltransferases of H. pylori: evidence of human host population isolation and migration","volume":"9","author":"Vale FF","year":"2009","journal-title":"BMC Microbiol"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1523-5378.2011.00825.x","article-title":"Antigenic diversity among Portuguese clinical isolates of H. pylori","volume":"16","author":"Vitoriano I","year":"2011","journal-title":"Helicobacter"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1128\/JCM.41.4.1480-1485.2003","article-title":"Evaluation of the effects of strain-specific antigen variation on the accuracy of serologic diagnosis of H. pylori infection","volume":"41","author":"Marchildon PA","year":"2003","journal-title":"J Clin Microbiol"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ijmm.2013.08.005","article-title":"H. pylori FliD protein is a highly sensitive and specific marker for serologic diagnosis of H. pylori infection","volume":"303","author":"Khalifeh Gholi M","year":"2013","journal-title":"Int J Med Microbiol"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1128\/CVI.00433-13","article-title":"A novel line immunoassay based on recombinant virulence factors enables highly specific and sensitive serologic diagnosis of H. pylori infection","volume":"20","author":"Formichella L","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1590\/S0100-879X1998001000005","article-title":"Serodiagnosis of H. pylori infection by Cobas Core ELISA in adults from Minas Gerais, Brazil","volume":"31","author":"Rocha GA","year":"1998","journal-title":"Bras J Med Biol Res"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1590\/S0074-02762004000200013","article-title":"Immunoblotting for the serodiagnosis of H. pylori infection in Brazilian patients with and without gastric carcinoma","volume":"99","author":"Rocha AM","year":"2004","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1128\/JCM.41.1.447-448.2003","article-title":"Accuracy of a commercial enzyme-linked immunosorbent assay for CagA in patients from Brazil with and without gastric carcinoma","volume":"41","author":"Rocha AM","year":"2003","journal-title":"J Clin Microbiol"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-2004-812836","article-title":"Diagnostics of H. pylori infection in patients with peptic ulcer bleeding","volume":"42","author":"Peitz U","year":"2004","journal-title":"Z Gastroenterol"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/003655200750024290","article-title":"Diagnosis of H. pylori infection in patients with atrophic gastritis: comparison of histology, 13C-urea breath test, and serology","volume":"35","author":"Kokkola A","year":"2000","journal-title":"Scan J Gastroenterol"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1572-0241.2003.t01-1-07264.x","article-title":"Which test to use to detect H. pylori infection in patients with low grade gastric MALT lymphoma?","volume":"98","author":"Lohours P","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/jac\/39.5.585","article-title":"In-vitro activity of lansoprazole against H. pylori","volume":"39","author":"Figura N","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1523-5378.1998.08024.x","article-title":"Growth inhibitory and bactericidal activities of lansoprazole compared with those of omeprazole and pantoprazole against H. pylori","volume":"3","author":"Nakao M","year":"1998","journal-title":"Helicobacter"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2036.2004.02021.x","article-title":"Masking of 13C urea breath test by proton pump inhibitors is dependent on type of medication: comparison between omeprazole, pantoprazole, lansoprazole and esomeprazole","volume":"20","author":"Levine A","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1046\/j.1365-2036.2002.01192.x","article-title":"Different effects of short-term omeprazole, lansoprazole or pantoprazole on the accuracy of the 13C-urea breath test","volume":"16","author":"Parente F","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.3748\/wjg.v19.i45.8188","article-title":"Stool antigen tests for the management of H. pylori infection","volume":"19","author":"Shimoyama T","year":"2013","journal-title":"World J Gastroenterol"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1097\/PAS.0b013e3181e51067","article-title":"H. pylori-negative gastritis: seek, yet ye shall not always find","volume":"34","author":"Genta RM","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"547","DOI":"10.7326\/0003-4819-129-7-199810010-00007","article-title":"Effect of proton-pump inhibitor therapy on diagnostic testing for H. pylori","volume":"129","author":"Laine L","year":"1998","journal-title":"Ann Intern Med"},{"key":"ref114","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/898276","article-title":"Comparing Multiplex PCR and rapid urease test in the detection of H. pylori in patients on proton pump inhibitors","volume":"2012","author":"Chen T","year":"2012","journal-title":"Gastroenterol Res Pract"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.3748\/wjg.14.1539","article-title":"Gastric juice for the diagnosis of H pylori infection in patients on proton pump inhibitors","volume":"14","author":"Yakoob J","year":"2008","journal-title":"World J Gastroenterol"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3748\/wjg.v20.i6.1438","article-title":"A review of H. pylori diagnosis, treatment, and methods to detect eradication","volume":"20","author":"Garza-Gonz\u00e1lez E","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref117","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.gtc.2015.05.001","article-title":"Diagnosis of H. pylori infection in the proton pump inhibitor era","volume":"44","author":"Calvet X","year":"2015","journal-title":"Gastroenterol Clin North Am"},{"key":"ref118","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/2050640615600968","article-title":"Diagnostic methods for H. pylori infection: choices, opportunities and pitfalls","volume":"3","author":"Malfertheiner P","year":"2015","journal-title":"United European Gastroenterol J"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10620-015-3877-4","article-title":"H. pylori Infection: diagnostic strategies in primary diagnosis and after therapy","volume":"61","author":"Atkinson NS","year":"2016","journal-title":"Dig Dis Sci"},{"key":"ref120","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/hel.12246","article-title":"Negative effect of proton-pump inhibitors (PPIs) on H. pylori growth, morphology, and urease test and recovery after PPI removal-An In vitro study","volume":"21","author":"Saniee P","year":"2016","journal-title":"Helicobacter"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/s13104-016-2237-6","article-title":"Comparison of endoscopic based diagnosis with Helicobacter urease test for H. pylori infection","volume":"9","author":"Adu-Aryee NA","year":"2016","journal-title":"BMC Res Notes"},{"key":"ref122","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1023\/A:1021931627698","article-title":"Impact of long-term ranitidine and pantoprazole on accuracy of [13C]urea breath test","volume":"48","author":"Dulbecco P","year":"2003","journal-title":"Dig Dis Sci"},{"key":"ref123","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1067\/mge.2002.120391","article-title":"Human plasma is directly bacteriocidal against H. pylori in vitro, potentially explaining the decreased detection of H. pylori during acute upper GI bleeding","volume":"55","author":"Houghton J","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"ref124","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1046\/j.1440-1746.2000.02171.x","article-title":"Rapid urease test is less sensitive than histology in diagnosing H. pylori infection in patients with non-variceal upper GI bleeding","volume":"15","author":"Archimandritis A","year":"2000","journal-title":"J Gastroenterol Hepatol"},{"key":"ref125","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/j.1572-0241.2000.02004.x","article-title":"Rapid urease tests lack sensitivity in H. pylori diagnosis when peptic ulcer disease presents with bleeding","volume":"95","author":"Lee JM","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"ref126","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1590-8658(03)00058-6","article-title":"A negative rapid urease test is unreliable for exclusion of H. pylori infection during acute phase of ulcer bleeding - A prospective case control study","volume":"35","author":"Schilling D","year":"2003","journal-title":"Dig Liver Dis"},{"key":"ref127","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MCG.0b013e31816466ec","article-title":"Endoscopic diagnosis of H. pylori infection by rapid urease test in bleeding peptic ulcers: A prospective case-control study","volume":"43","author":"Tang JH","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"ref128","first-page":"31","article-title":"Low sensitivity of invasive tests for the detection of H. pylori infection in patients with bleeding ulcer","volume":"24","author":"Colin R","year":"2000","journal-title":"Gastroenterol Clin Biol"},{"key":"ref129","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.gie.2005.09.019","article-title":"The effect of GI bleeding on H. pylori diagnostic testing: a prospective study at the time of bleeding and 1 month later","volume":"62","author":"Laine LA","year":"2005","journal-title":"Gastrointest Endosc"},{"key":"ref130","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s10620-014-3351-8","article-title":"Increasing biopsy number and sampling from gastric body improve the sensitivity of rapid urease test in patients with peptic ulcer bleeding","volume":"60","author":"Lee TH","year":"2015","journal-title":"Dig Dis Sci"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3748\/wjg.v11.i3.382","article-title":"Mucosal polymerase chain reaction for diagnosing H. pylori infection in patients with bleeding peptic ulcers","volume":"11","author":"Lin HJ","year":"2005","journal-title":"World J Gastroenterol"},{"key":"ref132","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1128\/JCM.01205-12","article-title":"Real-time PCR for diagnosing H. pylori infection in patients with upper gastrintestinal bleeding: Comparison with other classical diagnostic methods","volume":"50","author":"Saez J","year":"2012","journal-title":"J Clin Microbio"},{"key":"ref133","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1046\/j.1365-2036.2003.01548.x","article-title":"Antigen stool test for assessment of H. pylori infection in patients with upper gastrointestinal bleeding","volume":"17","author":"Peitz U","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"ref134","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/01.meg.0000059114.41030.a9","article-title":"Comparison of stool immunoassay with standard methods for detection of H. pylori infection in patients with upper-gastrointestinal bleeding of peptic origin","volume":"15","author":"Gri\u00f1\u00f3 P","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref135","first-page":"798","article-title":"Lack of accuracy of the noninvasive H. pylori stool antigen test in patients with gastroduodenal ulcer bleeding","volume":"98","author":"van Leerdam ME","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"ref136","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00004836-200307000-00010","article-title":"The usefulness of capsulated 13C-Urea Breath Test in diagnosis of H. pylori infection in patients with upper gastrointestinal bleeding","volume":"37","author":"Winiarski M","year":"2003","journal-title":"J Clin Gastroenterol"},{"key":"ref137","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1523-5378.2007.00492.x","article-title":"13C-Urea Breath Test during hospitalization for the diagnosis of H. pylori infection in peptic ulcer bleeding","volume":"12","author":"Gisbert JP","year":"2007","journal-title":"Helicobacter"},{"key":"ref138","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1007\/s10620-012-2096-5","article-title":"Accuracy of urea breath test performed immediately after emergency endoscopy in peptic ulcer bleeding","volume":"57","author":"Velayos B","year":"2012","journal-title":"Dig Dis Sci"},{"key":"ref139","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1572-0241.2006.00528.x","article-title":"Accuracy of H. pylori diagnostic tests in patients with bleeding peptic ulcer: a systematic review and meta-analysis","volume":"101","author":"Gisbert JP","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"ref140","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2036.2006.02726.x","article-title":"Usefulness of a delayed test for the diagnosis of H. pylori infection in bleeding peptic ulcer","volume":"23","author":"G\u00fcell M","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/MOG.0b013e328365d45d","article-title":"Dyspepsia","volume":"29","author":"Ford AC","year":"2013","journal-title":"Curr Opin Gastroenterol"},{"key":"ref142","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.3748\/wjg.v12.i17.2661","article-title":"Epidemiology of functional dispepsia: a global perspective","volume":"12","author":"Mahadeva S","year":"2006","journal-title":"World J Gastroenterol"},{"key":"ref143","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nrgastro.2013.14","article-title":"Functional dyspepsia - symptoms, definitions and validity of the Rome III criteria","volume":"10","author":"Tack J","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref144","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1590\/S0034-89102006000300009","article-title":"Preval\u00eancia de dispepsia e fatores s\u00f3cio-demogr\u00e1ficos","volume":"40","author":"Oliveira SS","year":"2006","journal-title":"Rev Saude Publica"},{"key":"ref145","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1053\/j.gastro.2016.02.011","article-title":"Gastroduodenal Disorders","volume":"150","author":"Stanghellini V","year":"2016","journal-title":"Gastroenterology"},{"key":"ref146","series-title":"Schistosomiase et g\u00e9ohelminthiases: prev\u00e9tion et lutte","volume":"912","year":"2004"},{"key":"ref147","article-title":"Eradication of Helicobacter pylori for non-ulcer dyspepsia","author":"Moayyedi P","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"ref148","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/ajg.2017.154","article-title":"ACG and CAG Clinical Guideline: Management of Dyspepsia","volume":"112","author":"Moayyedi PM","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"ref149","article-title":"Duodenal acid-induced gastric relaxation is mediated by multiple pathways","volume":"276","author":"Lu YX","year":"1999","journal-title":"Am J Physiol"},{"key":"ref150","first-page":"399","article-title":"Gut microbiota and pancreatic diseases","volume":"63","author":"Signoretti M","year":"2017","journal-title":"Minerva Gastroenterol Dietol"},{"key":"ref151","first-page":"G29","article-title":"Duodenal acidification releases cholecystokinin","volume":"249","author":"Chen YF","year":"1985","journal-title":"Am J Physiol"},{"key":"ref152","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/MOG.0b013e328331b62a","article-title":"Gastric exocrine and endocrine secretion","volume":"25","author":"Schubert ML","year":"2009","journal-title":"Curr Opin Gastroenterol"},{"key":"ref153","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/ejcn.2014.151","article-title":"Effect of dietary management on the gastric endocrine cells in patients with irritable bowel syndrome","volume":"69","author":"Mazzawi T","year":"2015","journal-title":"Eur J Clin Nutr"},{"key":"ref154","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1210\/me.2014-1108","article-title":"Minireview: gut microbiota: the neglected endocrine organ","volume":"28","author":"Clarke G","year":"2014","journal-title":"Mol Endocrinol"},{"key":"ref155","first-page":"591","article-title":"Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options","volume":"62","author":"Konturek PC","year":"2011","journal-title":"J Physiol Pharmacol"},{"key":"ref156","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/1568026611313030001","article-title":"TRP channels as therapeutic targets","volume":"13","author":"Kaneko Y","year":"2013","journal-title":"Curr Top Med Chem"},{"key":"ref157","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11882-012-0313-0","article-title":"Mucosal immunology and probiotics","volume":"13","author":"Dongarr\u00e0 ML","year":"2013","journal-title":"Curr Allergy Asthma Rep"},{"key":"ref158","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrmicro2536","article-title":"Shifting the balance: antibiotic effects on host-microbiota mutualism","volume":"9","author":"Willing BP","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"ref159","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1126\/science.aad9358","article-title":"Antibiotic use and its consequences for the normal microbiome","volume":"352","author":"Blaser MJ","year":"2016","journal-title":"Science"},{"issue":"3","key":"ref160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009836","article-title":"Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome","volume":"5","author":"Jakobsson HE","year":"2010","journal-title":"PLoS One"},{"issue":"11","key":"ref161","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1136\/gutjnl-2016-312297","article-title":"Antibiotics as deep modulators of gut microbiota: between good and evil","volume":"65","author":"Ianiro G","year":"2016","journal-title":"Gut"},{"key":"ref162","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/hel.12237","article-title":"Emerging role of probiotics in the management of Helicobacter pylori infection: Histopathologic perspectives","volume":"21","author":"Emara MH","year":"2016","journal-title":"Helicobacter"},{"key":"ref163","first-page":"88","article-title":"Role of probiotics in managing of Helicobacter pylori infection: A review","volume":"67","author":"Kafshdooz T","year":"2017","journal-title":"Drug Res (Stuttg)"},{"key":"ref164","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.micpath.2017.05.035","article-title":"Effects of anti-Helicobacter pylori concomitant therapy and probiotic supplementation on the throat and gut microbiota in humans","volume":"109","author":"Wang ZJ","year":"2017","journal-title":"Microb Pathog"},{"key":"ref165","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.3748\/wjg.v18.i43.6302","article-title":"Adjuvant probiotics improve the eradication effect of triple therapy for Helicobacter pylori infection","volume":"18","author":"Du YQ","year":"2012","journal-title":"World J Gastroenterol"},{"key":"ref166","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s11274-013-1490-2","article-title":"Effect of Lactobacillus acidophilus and Bifidobacterium bifidum supplementation to standard triple therapy on Helicobacter pylori eradication and dynamic changes in intestinal flora","volume":"30","author":"Wang YH","year":"2014","journal-title":"World J Microbiol Biotechnol"},{"key":"ref167","article-title":"Probiotic supplementation does not improve eradication rate of Helicobacter pylori infection compared to placebo based on standard therapy: a meta-analysis","volume":"6","author":"Lu C","year":"2016","journal-title":"Sci Rep"},{"key":"ref168","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-230X-13-56","article-title":"Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study","volume":"13","author":"Navarro-Rodriguez T","year":"2013","journal-title":"BMC Gastroenterol"},{"key":"ref169","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.gastrohep.2016.05.003","article-title":"IV Spanish Consensus Conference on Helicobacter pylori infection treatment","volume":"39","author":"Gisbert JP","year":"2016","journal-title":"Gastroenterol Hepatol"},{"key":"ref170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/jgh.13911","article-title":"Helicobacter pylori management in ASEAN: The Bangkok consensus report. Helicobacter pylori management in ASEAN: The Bangkok consensus report","volume":"33","author":"Mahachai V","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3748\/wjg.v20.i6.1379","article-title":"Helicobacter pylori infection and extragastric disorders in children: A critical update","volume":"20","author":"Pacifico L","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref172","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12330","article-title":"An updated systematic review and meta-analysis on the association between Helicobacter pylori infection and iron deficiency anemia","volume":"22","author":"Hudak L","year":"2017","journal-title":"Helicobacter"},{"key":"ref173","doi-asserted-by":"crossref","first-page":"356","DOI":"10.5009\/gnl14483","article-title":"The effects of Helicobacter pylori eradication therapy for chronic idiopathic thrombocytopenic purpura","volume":"10","author":"Hwang JJ","year":"2016","journal-title":"Gut Liver"},{"key":"ref174","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/hel.12200","article-title":"Helicobacter pylori eradication in patients with immune thrombocytopenic purpura: a review and the role of biogeography","volume":"20","author":"Galit HF","year":"2015","journal-title":"Helicobacter"},{"key":"ref175","first-page":"346","article-title":"Helicobacter pylori, a causative agent of vitamin B12 deficiency","volume":"2","author":"Abdel S","year":"2008","journal-title":"J Infect Developing Countries"},{"key":"ref176","doi-asserted-by":"crossref","first-page":"11950","DOI":"10.3748\/wjg.v20.i34.11950","article-title":"Extraintestinal manifestations of Helicobacter pylori: a concise review","volume":"20","author":"Wong F","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref177","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3109\/00365521003663670","article-title":"Iron deficiency anemia in Helicobacter pylori infection: meta-analysis of randomized controlled trials","volume":"45","author":"Yuan W","year":"2010","journal-title":"Scand J Gastroenterol"},{"key":"ref178","first-page":"886","article-title":"Does Helicobacter pylori infection play a role in iron deficiency anemia? A meta-analysis","volume":"16","author":"Qu XH","year":"2010","journal-title":"World J Gastroenterol"},{"key":"ref179","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1136\/gut.2010.228874","article-title":"Guidelines for the management of iron deficiency anaemia","volume":"60","author":"Goddard AF","year":"2011","journal-title":"Gut"},{"key":"ref180","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/ajh.20250","article-title":"Helicobacter pylori eradication: novel therapy for immune thrombocytopenic purpura? A review of the literature","volume":"78","author":"Jackson S","year":"2005","journal-title":"Am J Hematol"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1572-0241.2005.41641.x","article-title":"Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura-a randomized controlled trial","volume":"100","author":"Suzuki T","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"ref182","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00277-005-1071-z","article-title":"Randomized study of Helicobacter pylori eradication therapy and proton pump inhibitor monotherapy for idiopathic thrombocytopenic purpura","volume":"84","author":"Tsutsumi Y","year":"2005","journal-title":"Ann Hematol"},{"key":"ref183","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1651-2227.2003.tb02476.x","article-title":"Efficacy of Helicobacter pylori eradication on platelet recovery in children with chronic idiopathic thrombocytopenic purpura","volume":"92","author":"Jaing TH","year":"2003","journal-title":"Acta Paediatr"},{"key":"ref184","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1182\/blood-2008-07-167155","article-title":"Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review","volume":"113","author":"Stasi R","year":"2009","journal-title":"Blood"},{"key":"ref185","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3109\/09537104.2014.911836","article-title":"Helicobacter pylori infection & immune thrombocytopenic purpura in children and adolescents: A randomized controlled trial","volume":"26","author":"Brito HS","year":"2015","journal-title":"Platelets"},{"key":"ref186","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.3748\/wjg.v23.i22.3964","article-title":"Molecular mimicry in Helicobacter pylori infections","volume":"23","author":"Chmiela M","year":"2017","journal-title":"World J Gastroenterol"},{"key":"ref187","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1056\/NEJMcp1113996","article-title":"Vitamin B12 deficiency","volume":"368","author":"Stabler SP","year":"2013","journal-title":"N Engl J Med"},{"key":"ref188","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/gut.2006.095125","article-title":"Long-term effect of Helicobacter pylori eradication on plasma homocysteine in elderly patients with cobalamin deficiency","volume":"56","author":"Marino MC","year":"2007","journal-title":"Gut"},{"key":"ref189","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.5551\/jat.25775","article-title":"Helicobacter pylori-an infectious risk factor for atherosclerosis?","volume":"21","author":"He C","year":"2014","journal-title":"J Atheroscler Thromb"},{"key":"ref190","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/hel.12234","article-title":"A meta-analysis of the association between Helicobacter pylori infectionand risk of coronary heart disease from published prospective studies","volume":"21","author":"Sun J","year":"2016","journal-title":"Helicobacter"},{"issue":"11","key":"ref191","article-title":"Helicobacter pylori eradication for Parkinson\u2019s disease","author":"Rees K","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"ref192","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.parkreldis.2015.05.015","article-title":"The association between infectious burden and Parkinson\u2019s disease: a case-control study","volume":"21","author":"Bu XL","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"ref193","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/cea.12404","article-title":"Is Helicobacter pylori infection inversely associated with atopy? A systematic review and meta-analysis","volume":"45","author":"Taye B","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"ref194","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/apt.13560","article-title":"Helicobacter pylori infection is associated with a reduced risk of developing eosinophilic oesophagitis","volume":"43","author":"von Armin U Wex T","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"ref195","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/bmj.326.7392.737","article-title":"Prevalence of H. pylori in patients with gastro-oesophageal reflux disease: systematic review","volume":"326","author":"Raghunath A","year":"2003","journal-title":"BMJ"},{"key":"ref196","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1523-5378.2007.00466.x","article-title":"H. pylori infection and gastroesophageal reflux in a population-based study (The HUNT Study)","volume":"12","author":"Nordenstedt H","year":"2007","journal-title":"Helicobacter"},{"key":"ref197","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cgh.2013.08.029","article-title":"Association between Helicobacter pylori and Barrett\u2019s esophagus, erosive esophagitis, and gastroesophageal reflux symptoms","volume":"12","author":"Rubenstein JH","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref198","doi-asserted-by":"crossref","first-page":"267","DOI":"10.5056\/jnm.2011.17.3.267","article-title":"H. pylori serology inversely correlated with the risk and severity of reflux esophagitis in H. pylori endemic area: a matched case- control study of 5,616 health check-up Koreans","volume":"17","author":"Chung SJ","year":"2011","journal-title":"J Neurogastroenterol Motil"},{"key":"ref199","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4291\/wjgp.v5.i3.178","article-title":"Barrett\u00b4s esophagus: evidence from the current meta-analyses","volume":"5","author":"Gatenby P","year":"2014","journal-title":"World J Gastrointest Pathophysiol"},{"key":"ref200","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/hel.12337","article-title":"H. pylori and non-malignant upper gastrointestinal diseases","volume":"21","author":"Vasapolli R","year":"2016","journal-title":"Helicobacter"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1523-5378.2011.00931.x","article-title":"The association between Barrett\u2019s esophagus and H. pylori infection: a meta-analysis","volume":"17","author":"Fischbach LA","year":"2012","journal-title":"Helicobacter"},{"key":"ref202","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1136\/gut.2007.132662","article-title":"Relationship between H. pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study","volume":"57","author":"Anderson LA","year":"2008","journal-title":"Gut"},{"key":"ref203","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ajg.2008.37","article-title":"H. pylori infection and Barrett\u2019s esophagus: a systematic review and meta-analysis","volume":"104","author":"Wang C","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"ref204","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/00365521.2011.648955","article-title":"Effect of H. pylori treatment on gastroesophageal reflux disease (GERD): meta-analysis of randomized controlled trials","volume":"47","author":"Saad AM","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"ref205","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1523-5378.2011.00846.x","article-title":"Effects of H. pylori eradication on gastroesophageal reflux disease","volume":"16","author":"Qian B","year":"2011","journal-title":"Helicobacter"},{"key":"ref206","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/ajg.2009.734","article-title":"Is there an increased risk of GERD after H. pylori eradication?: a meta- analysis","volume":"105","author":"Yaghoobi M","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"ref207","doi-asserted-by":"crossref","first-page":"995","DOI":"10.4103\/0366-6999.155049","article-title":"Effect of H. pylori eradication on reflux esophagitis therapy: a multi-center randomized control study","volume":"128","author":"Xue Y","year":"2015","journal-title":"Chin Med J (Engl)"},{"key":"ref208","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.gtc.2010.08.010","article-title":"Nonsteroidal anti-inflammatory drug-related injury to the gastrointestinal tract: clinical picture, pathogenesis, and prevention","volume":"39","author":"Scarpignato C","year":"2010","journal-title":"Gastroenterol Clin North Am"},{"key":"ref209","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0140-6736(84)91816-6","article-title":"Unidentified cueved bacilli in the stomach of patients with gastritis and peptic ulceration","volume":"1","author":"Marshall BJ","year":"1984","journal-title":"Lancet"},{"key":"ref210","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(02)07273-2","article-title":"Role of H. pylori and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis","volume":"359","author":"Huang JQ","year":"2002","journal-title":"Lancet"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2036.2002.01230.x","article-title":"H. pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin","volume":"16","author":"Lanas A","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"ref212","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s00535-013-0839-5","article-title":"Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study","volume":"49","author":"Uemura N","year":"2014","journal-title":"J Gastroenterol"},{"key":"ref213","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5009\/gnl14372","article-title":"Does H. pylori exacerbates gastric mucosal injury in users of nonsteroidal anti-inflammatory drugs? A multicenter, restrospective, case-control study","volume":"10","author":"Kono Y","year":"2016","journal-title":"Gut and Liver"},{"key":"ref214","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00535-014-0976-5","article-title":"Identification of a high-risk group for low-dose aspirin-induced gastropathy by measuring s\u00e9rum pepsinogen in H. pylori-infected subjects","volume":"50","author":"Iijima K","year":"2015","journal-title":"J Gastroenterol"},{"key":"ref215","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/ajg.2015.98","article-title":"Peptic ulcer bleeding risk. The role of H. pylori infection in NSAID\/low-dose aspirin users","volume":"110","author":"Sostres C","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"ref216","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.cgh.2014.11.007","article-title":"Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants","volume":"13","author":"Lanas \u00c1","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref217","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/j.gastro.2013.02.041","article-title":"New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis","volume":"145","author":"Holster IL","year":"2013","journal-title":"Gastroenterology"},{"key":"ref218","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.3748\/wjg.v23.i11.1954","article-title":"Gastrointestinal bleeding in patients on novel oral anticoagulants: risk, prevention and management","volume":"23","author":"Cheung KS","year":"2017","journal-title":"World J Gastroenterol"},{"key":"ref219","doi-asserted-by":"crossref","first-page":"787","DOI":"10.7326\/0003-4819-115-10-787","article-title":"Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis","volume":"115","author":"Gabriel SE","year":"1991","journal-title":"Ann Intern Med"},{"key":"ref220","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1053\/gast.2002.36013","article-title":"Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of double-blind outcomes study in patients with rheumatoid arthritis","volume":"123","author":"Laine L","year":"2002","journal-title":"Gastroenterology"},{"key":"ref221","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-016-0718-z","article-title":"Effective and safe pump inhibitor therapy in acid-related diseases- a position paper addressing benefits and potential harms of acid suppression","volume":"14","author":"Scarpignato C","year":"2016","journal-title":"BMC Medicine"},{"key":"ref222","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1053\/j.gastro.2012.12.038","article-title":"Effects of H. pylori infection on long-term risk of peptic ulcer bleeding in low-dose aspirin isers","volume":"144","author":"Chan FK","year":"2013","journal-title":"Gastroenterology"},{"key":"ref223","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.dld.2015.06.010","article-title":"Guidelines for the management of H. pylori infection: The III Working Consensus Report 2015","volume":"47","author":"Zagari RM","year":"2015","journal-title":"Dig Liv Dis"},{"key":"ref224","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1136\/gutjnl-2014-307595","article-title":"The stomach in health and disease","volume":"64","author":"Hunt RH","year":"2015","journal-title":"Gut"},{"key":"ref225","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa012877","article-title":"Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use","volume":"346","author":"Lai KC","year":"2002","journal-title":"N Engl J Med"},{"key":"ref226","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1053\/j.gastro.2004.07.010","article-title":"Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: results of a randomized double-blind trial","volume":"127","author":"Chan FK","year":"2004","journal-title":"Gastroenterology"},{"issue":"1621-6","key":"ref227","article-title":"Combination of a cyclo-oxigenase-2 inhibitor and a proton pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomized trial","volume":"369","author":"Chan FK","year":"2007","journal-title":"Lancet"},{"key":"ref228","series-title":"World Health Statistics","year":"2013"},{"key":"ref229","series-title":"Incid\u00eancia de C\u00e2ncer no Brasil. Coordena\u00e7\u00e3o de Preven\u00e7\u00e3o e Vigil\u00e2ncia Estimativa 2016: Coordena\u00e7\u00e3o de Preven\u00e7\u00e3o e Vigil\u00e2ncia","year":"2016"},{"key":"ref230","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/annonc\/mdi086","article-title":"Trends in cancer mortality in the Americas, 1970-2000","volume":"16","author":"Bosetti C","year":"2005","journal-title":"Ann Oncol"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/CEJ.0b013e32834653c9","article-title":"Trends in cancer mortality in Mexico, 1981-2007","volume":"20","author":"Bosetti C","year":"2011","journal-title":"Eur J Cancer Prev"},{"key":"ref232","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/CEJ.0b013e32833233be","article-title":"Trends in cancer mortality in Brazil, 1980-2004","volume":"19","author":"Chatenoud L","year":"2010","journal-title":"Eur J Cancer Prev"},{"key":"ref233","first-page":"1009","article-title":"Cancer mortality trends in Brazilian state capitals and other municipalities between 1980 and 2006","volume":"45","author":"Silva GA","year":"2011","journal-title":"Rev Saude Publica"},{"key":"ref234","first-page":"1611","article-title":"Survival in gastric cancer patients in Campinas, S\u00e3o Paulo, Brazil","volume":"22","author":"Bustamante-Teixeira MT","year":"2006","journal-title":"Cad Saude Publica"},{"key":"ref235","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S2214-109X(16)30143-7","article-title":"Global burden of cancers attributable to infections in 2012: a synthetic analysis","volume":"4","author":"Plummer M","year":"2016","journal-title":"Lancet Glob Health"},{"key":"ref236","series-title":"Biological agents. IARC Monogr Eval Carcinog Risks Hum","first-page":"1","volume":"100B","year":"2012"},{"key":"ref237","first-page":"59","article-title":"Helicobacter pylori Infection and Gastric Adenocarcinoma","volume":"7","author":"Correa P","year":"2011","journal-title":"US Gastroenterol Hepatol Rev"},{"key":"ref238","first-page":"414","article-title":"A systematic review and meta-analysis of the role of Helicobacter pylori eradication in preventing gastric cancer","volume":"30","author":"Rokkas T","year":"2017","journal-title":"Ann Gastroenterol"},{"issue":"9","key":"ref239","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw132","article-title":"Eradication of Helicobacter pylori and Gastric Cancer: A Systematic Review and Meta-analysis of Cohort Studies","volume":"108","author":"Doorakkers E","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"ref240","article-title":"Helicobacter pylori eradication on the prevention of metachronous lesions after endoscopic resection of gastric neoplasm: a meta-analysis","volume":"10","author":"Jung DH","year":"2015","journal-title":"PLoS One"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/jgh.13249","article-title":"Incomplete type of intestinal metaplasia has the highest risk to progress to gastric cancer: results of the Spanish follow-up multicenter study","volume":"31","author":"Gonz\u00e1lez CA","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"ref242","doi-asserted-by":"crossref","first-page":"765","DOI":"10.5858\/2004-128-765-DTITIA","article-title":"Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: increase in the signet ring cell type","volume":"128","author":"Henson DE","year":"2004","journal-title":"Arch Pathol Lab Med"},{"key":"ref243","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1158\/1055-9965.EPI-09-0250","article-title":"Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site","volume":"18","author":"Wu H","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref244","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1590\/S0004-28032012000300002","article-title":"Gastric adenocarcinoma trends in the central region of Rio Grande do Sul (Southern Brazil): what has changed in 25 years?","volume":"49","author":"Rampazzo A","year":"2012","journal-title":"Arq Gastroenterol"},{"key":"ref245","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.3748\/wjg.v20.i17.4948","article-title":"Participation of microbiota in the development of gastric cancer","volume":"20","author":"Wang LL","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref246","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0016-5085(82)90118-4","article-title":"Pepsinogens I and II: purification from gastric mucosa and radioimmunoassay in serum","volume":"82","author":"Samloff IM","year":"1982","journal-title":"Gastroenterology"},{"key":"ref247","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.dld.2008.02.028","article-title":"Non-invasive tests in gastric diseases","volume":"40","author":"di Mario F","year":"2008","journal-title":"Dig Liv Dis"},{"key":"ref248","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1007\/s00535-005-1677-x","article-title":"Serum pepsinogen concentrations as a measure of gastric acid secretion in H. pylori- negative and - positive Japanese subjects","volume":"40","author":"Iijima K","year":"2005","journal-title":"J Gastroenterol"},{"key":"ref249","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cgh.2005.11.003","article-title":"Noninvasive versus histologic detection of gastric atrophy in a Hispanic population in North America","volume":"4","author":"Graham DY Nurgalieva ZZ","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref250","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-230X-12-10","article-title":"Serological assessment of gastric mucosal atrophy in gastric cance","volume":"12","author":"Bornschein J","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/MEG.0b013e32834d0a0a","article-title":"Serum pepsinogen test for early detection of gastric cancer in a European country","volume":"24","author":"Lomba-Viana R","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref252","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1258\/0969141041732184","article-title":"Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening","volume":"11","author":"Dinis-Ribeiro M","year":"2004","journal-title":"J Med Screen"},{"key":"ref253","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10120-006-0397-0","article-title":"Gastric cancer screening using the serum pepsinogen test method","volume":"9","author":"Miki K","year":"2006","journal-title":"Gastric Cancer"},{"key":"ref254","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3109\/00365521.2011.645501","article-title":"Rationale in diagnosis and screening of atrophic gastritis with stomach- specific plasma biomarkers","volume":"47","author":"Agr\u00e9us L","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"ref255","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12876-017-0641-6","article-title":"The potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in China: a diagnostic clinical research","volume":"17","author":"Tong Y","year":"2017","journal-title":"BMC Gastroenterology"},{"key":"ref256","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.semcancer.2013.07.004","article-title":"Eradication of gastric cancer is now both possible and practical","volume":"23","author":"Shiotani A","year":"2013","journal-title":"Semin Cancer Biol"},{"key":"ref257","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1443-9573.2007.00271.x","article-title":"Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and H. pylori immunoglobulin G antibodies","volume":"8","author":"Cao Q","year":"2007","journal-title":"J Dig Dis"},{"key":"ref258","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1080\/00365520902745062","article-title":"Clinical use of proton-pump inhibitors but not H2-blockers or antacid\/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population","volume":"44","author":"Agreus L","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"ref259","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1007\/s10620-009-0947-5","article-title":"The validity of a biomarker method for indirect detection of gastric mucosal atrophy versus standard histopathology","volume":"54","author":"Leja M","year":"2009","journal-title":"Dig Dis Sci"},{"key":"ref260","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1523-5378.2006.00392.x","article-title":"Design and planned analyses of an ongoing randomized trial assessing the preventive effect of H. pylori eradication on occurrence of new gastric carcinomas after endoscopic resection","volume":"11","author":"Kikuchi S","year":"2006","journal-title":"Helicobacter"},{"key":"ref261","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12393","article-title":"Detection of gastric atrophy by circulating pepsinogens: A comparison of three assays","volume":"22","author":"Leja M","year":"2017","journal-title":"Helicobacter"},{"key":"ref262","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109783","article-title":"Prediction of gastric cancer development by serum pepsinogen test and H. pylori seropositivity in Eastern Asians: a systematic review and meta-analysis","volume":"9","author":"Terasawa T","year":"2014","journal-title":"PloS One"},{"key":"ref263","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.21873\/anticanres.11083","article-title":"A panel of serum biomarkers (GastroPanel\u00ae) in non-invasive diagnosis of atrophic gastritis. Systematic review and meta-analysis","volume":"36","author":"Syrj\u00e4nen K","year":"2016","journal-title":"Anticancer Research"},{"key":"ref264","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/apt.14248","article-title":"Systematic review with metaanalysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-H. pylori antibodies serum assays for the diagnosis of atrophic gastritis","volume":"46","author":"Zagari RM","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"ref265","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.4067\/S0034-98872007001200003","article-title":"Detecci\u00f3n de lesiones preneopl\u00e1sicas g\u00e1stricas mediante niveles s\u00e9ricos de pepsin\u00f3geno en poblaci\u00f3n chilena","volume":"135","author":"Fern\u00e1ndez J","year":"2007","journal-title":"Rev M\u00e9d Chile"},{"key":"ref266","first-page":"564","article-title":"Ethnic differences in serum pepsinogen levels among Japanese and non-Japanese Brazilian gastric cancer patients and controls","volume":"24","author":"Fahey MT","year":"2000","journal-title":"Cancer Detect Prev"},{"key":"ref267","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jcmgh.2016.12.001","article-title":"The clinical evidence linking Helicobacter pylori to gastric Cancer","volume":"3","author":"Moss SF","year":"2016","journal-title":"Review Cell Mol Gastroenterol Hepatol"},{"key":"ref268","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","article-title":"Global burden of cancers attributable to infections in 2008: a review and synthetic analysis","volume":"13","author":"de Martel C","year":"2012","journal-title":"Lancet Oncol"},{"key":"ref269","series-title":"Helicobacter pylori Eradication as a Strategy for Gastric Cancer Prevention"},{"key":"ref270","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.bpg.2014.10.003","article-title":"The fight against gastric cancer-the IARC Working Group report","volume":"28","author":"Herrero R","year":"2014","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0016-5085(00)70410-0","article-title":"Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori","volume":"118","author":"El-Omar E","year":"2000","journal-title":"Gastroenterology"},{"key":"ref272","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000151297","article-title":"Gastric precancerous lesions and Helicobacter pylori infection in relatives of gastric cancer patients from Northeastern Brazil","volume":"78","author":"Motta CR","year":"2008","journal-title":"Digestion"},{"key":"ref273","doi-asserted-by":"crossref","first-page":"149","DOI":"10.15430\/JCP.2013.18.2.149","article-title":"Risk factors of atrophic gastritis and intestinal metaplasia in first-degree relatives of gastric cancer patients compared with age-sex matched controls","volume":"18","author":"Oh S","year":"2013","journal-title":"J Cancer Prev"},{"key":"ref274","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1136\/gutjnl-2012-302240","article-title":"The benefit of mass eradication of Helicobacter pylori infection: a community based study of gastric cancer prevention","volume":"62","author":"Lee YC","year":"2013","journal-title":"Gut"},{"key":"ref275","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/gutjnl-2015-309197","article-title":"A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication","volume":"65","author":"Pan KF","year":"2016","journal-title":"Gut"},{"key":"ref276","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1007\/s10620-010-1351-x","article-title":"H. pylori infection is a key risk factor for proximal gastric cancer","volume":"55","author":"Bornschein J","year":"2010","journal-title":"Dig Dis Sci"},{"key":"ref277","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/MCG.0b013e318260177a","article-title":"Diverging trends in the incidence of reflux-related and Helicobacter pylori-related gastric cardia cancer","volume":"47","author":"Abrams JA","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"ref278","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000336352","article-title":"Relationship between gastroesophageal junction adenocarcinoma and Helicobacter pylori infection in Japan","volume":"85","author":"Kamada T","year":"2012","journal-title":"Digestion"},{"key":"ref279","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow SH","year":"2008"},{"key":"ref280","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1016\/j.ejca.2008.07.005","article-title":"Gastric MALT lymphoma: epidemiology and high adenocarcinoma risk in a nation-wide study","volume":"44","author":"Capelle LG","year":"2008","journal-title":"Eur J Cancer"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/gutjnl-2011-300495","article-title":"Japan Gast Study Group. Long-term clinical outcome of gastric MALT lymphoma after eradication of H. pylori: a multicentre cohort follow-up study of 420 patients in Japan","volume":"61","author":"Nakamura S","year":"2012","journal-title":"Gut"},{"key":"ref282","series-title":"Tumors of the esophagus and stomach, Atlas of tumor pathology","volume":"vol. 3rd series","author":"Lewin KJ","year":"1996"},{"key":"ref283","doi-asserted-by":"crossref","first-page":"vi144","DOI":"10.1093\/annonc\/mdt343","article-title":"Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Zucca E","year":"2013","journal-title":"Ann Oncol"},{"key":"ref284","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/annonc\/mds643","article-title":"ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma","volume":"24","author":"Dreyling M","year":"2013","journal-title":"Ann Oncol"},{"key":"ref285","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/gut.2010.224949","article-title":"EGILS Consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT","volume":"60","author":"Ruskon\u00e9-Fourmestraux A","year":"2011","journal-title":"Gut"},{"key":"ref286","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/jcp.48.5.395","article-title":"The biology of low grade MALT lymphoma","volume":"48","author":"Isaacson PG","year":"1995","journal-title":"J Clin Pathol"},{"key":"ref287","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1590\/S0004-28032014000200003","article-title":"Helicobacter pylori and t(11;18)(q21;q21) translocation in gastric MALT lymphoma","volume":"51","author":"Lima KS","year":"2014","journal-title":"Arq Gastroenterol"},{"key":"ref288","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/0016-5085(92)91723-H","article-title":"Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis","volume":"102","author":"Radaszkiewicz T","year":"1992","journal-title":"Gastroenterology"},{"key":"ref289","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/oxfordjournals.annonc.a058869","article-title":"Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma","volume":"5","author":"Rohatiner A","year":"1994","journal-title":"Ann Oncol"},{"key":"ref290","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1136\/gut.52.6.912","article-title":"Paris staging system for primary gastrointestinal lymphomas","volume":"52","author":"Ruskon\u00e9-Fourmestraux A","year":"2003","journal-title":"Gut"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-3-319-13150-4_9","article-title":"Management of the marginal zone lymphomas","volume":"165","author":"Vannata B","year":"2015","journal-title":"Cancer Treat Res"},{"key":"ref292","doi-asserted-by":"crossref","first-page":"8014","DOI":"10.3748\/wjg.v21.i26.8014","article-title":"Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review","volume":"21","author":"Asano N","year":"2015","journal-title":"World J Gastroenterol"},{"key":"ref293","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00277-014-2298-3","article-title":"Antibiotic treatment as sole management of Helicobacter pylori-negative gastric MALT lymphoma: a single center experience with prolonged follow-up","volume":"94","author":"Raderer M","year":"2015","journal-title":"Ann Hematol"},{"key":"ref294","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0046-8177(98)90443-9","article-title":"Le lymphome imaginaire","volume":"29","author":"Genta RM","year":"1998","journal-title":"Hum Pathol"},{"key":"ref295","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/gut.52.11.1656","article-title":"Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma","volume":"52","author":"Copie-Bergman C","year":"2003","journal-title":"Gut"},{"key":"ref296","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.dld.2017.12.006","article-title":"Gastrointestinal lymphomas: French Intergroup clinical practice recommendations for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFH)","volume":"50","author":"Matysiak-Budnika T","year":"2018","journal-title":"Dig Liv Dis"},{"key":"ref297","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0140-6736(75)90498-5","article-title":"A model for gastric cancer epidemiology","volume":"2","author":"Correa P","year":"1975","journal-title":"Lancet"},{"key":"ref298","first-page":"6735","article-title":"Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention","volume":"52","author":"Correa P","year":"1992","journal-title":"Cancer Res"},{"key":"ref299","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/ijc.11680","article-title":"Progression of chronic atrophic gastritis associated with H. pylori infection increases risk of gastric cancer","volume":"109","author":"Ohata H","year":"2004","journal-title":"Int J Cancer"},{"key":"ref300","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4251\/wjgo.v7.i12.455","article-title":"H. pylori in gastric carcinogenesis","volume":"7","author":"Ahn HJ","year":"2015","journal-title":"World J Gastroenterol Oncol"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.bpg.2016.09.004","article-title":"Surveillance of patients with gastric precancerous conditions","volume":"30","author":"Lage J","year":"2016","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref302","doi-asserted-by":"crossref","first-page":"25","DOI":"10.15430\/JCP.2015.20.1.25","article-title":"Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer","volume":"20","author":"Park YH","year":"2015","journal-title":"J Cancer Prev"},{"key":"ref303","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1523-5378.2008.00604.x","article-title":"Prevalence and risk factors of atrophic gastritis and intestinal metaplasia in a Korean population without significant gastroduodenal disease","volume":"13","author":"Kim N","year":"2008","journal-title":"Helicobacter"},{"key":"ref304","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3109\/07853899509002475","article-title":"Geographical pathology of H. pylori infection: is there more than one gastritis?","volume":"27","author":"Genta RM","year":"1995","journal-title":"Ann Med"},{"key":"ref305","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1053\/hupa.2001.20889","article-title":"Gastric atrophy and extent of intestinal metaplasia in a cohort of H. pylori-infected patients","volume":"32","author":"Guarner J","year":"2001","journal-title":"Hum Pathol"},{"key":"ref306","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1097\/00004836-200305001-00006","article-title":"Gastric Atrophy, metaplasia, and dysplasia: a clinical perspective","volume":"36","author":"Kapadia CR","year":"2003","journal-title":"J Clin Gastroenterol"},{"key":"ref307","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1365-2036.2012.05227.x","article-title":"Gastric atrophy as a precursor of gastric cancer (letter)","volume":"36","author":"Barbosa AJA","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"ref308","series-title":"Gastrointestinal endoscopy","first-page":"169","volume-title":"Atrophic Body gastritis: a challenge for the presumptive endoscopic and histologic diagnosis of autoimmune gastritis","author":"Barbosa AJA","year":"2011"},{"key":"ref309","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/BF01002633","article-title":"The mucin profiles of normal gastric mucosa, intestinal metaplasia and its variants and gastric carcinoma","volume":"13","author":"Jass JR","year":"1981","journal-title":"Histochem J"},{"key":"ref310","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/ijc.28003","article-title":"Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence","volume":"133","author":"Gonzalez CA","year":"2003","journal-title":"Int J Cancer"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000368807","article-title":"Relationship between the degree of endoscopic atrophy of the gastric mucosa and carcinogenic risk","volume":"91","author":"Masuyama H","year":"2015","journal-title":"Digestion"},{"key":"ref312","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-5378.2007.00475.x","article-title":"The detection, surveillance and treatment of premalignant gastric lesions related to H. pylori infection","volume":"12","author":"de Vries AC","year":"2007","journal-title":"Helicobacter"},{"key":"ref313","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1440-1746.2008.05546.x","article-title":"Role of intestinal metaplasia subtyping in the risk of gastric cancer in Korea","volume":"24","author":"Kang KP","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"ref314","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2036.1998.00003.x","article-title":"Gastric atrophy and atrophic gastritis--nebulous concepts in search of a definition","volume":"12","author":"Genta RM","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"ref315","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000321529","article-title":"Gastric atrophy reversible or irreversible after H. pylori eradication - An open question","volume":"83","author":"Malfertheiner P","year":"2011","journal-title":"Digestion"},{"key":"ref316","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1365-2036.2010.04277.x","article-title":"Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study","volume":"31","author":"Rugge M","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"ref317","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/gut.2006.106666","article-title":"Gastritis staging in clinical practice: the OLGA staging system","volume":"56","author":"Rugge M","year":"2007","journal-title":"Gut"},{"key":"ref318","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.gie.2009.12.029","article-title":"The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis","volume":"71","author":"Capelle LG","year":"2010","journal-title":"Gastrointest Endosc"},{"key":"ref319","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00428-014-1544-3","article-title":"Gastritis staging: interobserver agreement by applying OLGA and OLGIM systems","volume":"464","author":"Isajevs S","year":"2014","journal-title":"Virchows Arch"},{"key":"ref320","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-0031-1291491","article-title":"Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED)","volume":"44","author":"Dinis-Ribeiro M","year":"2012","journal-title":"Endoscopy"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.cgh.2017.05.023","article-title":"Gastric Cancer as Preventable Disease","volume":"15","author":"Rugge M","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref322","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.dld.2008.02.030","article-title":"OLGA staging for gastritis: a tutorial","volume":"40","author":"Rugge M","year":"2008","journal-title":"Dig Liver Dis"},{"key":"ref323","article-title":"Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients","author":"Rugge M","year":"2018","journal-title":"Gut Published Online First"},{"key":"ref324","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/apt.13497","article-title":"The global emergence of H. pylori antibiotic resistance","volume":"43","author":"Thung I","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"ref325","article-title":"Comparative effectiveness and tolerance of treatments for H. pylori: systematic review and network meta-analysis","volume":"351","author":"Li BZ","year":"2015","journal-title":"BMJ"},{"key":"ref326","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.dld.2015.12.001","article-title":"The relationship between the failure to eradicate H. pylori and previous antibiotics use","volume":"48","author":"Lim SG","year":"2016","journal-title":"Dig Liver Dis"},{"key":"ref327","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gutjnl-2012-302254","article-title":"H. pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption","volume":"62","author":"Megraud F","year":"2013","journal-title":"Gut"},{"key":"ref328","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1111\/j.1572-0241.2006.00717.x","article-title":"The effect of CYP2C19 polymorphisms on H. pylori eradication rate in dual and triple first-line PPI therapies: a meta-analysis","volume":"101","author":"Padol S","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"ref329","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.amjmed.2005.10.003","article-title":"Smoking increases the treatment failure for H. pylori eradication","volume":"119","author":"Suzuki T","year":"2006","journal-title":"Am J Med"},{"key":"ref330","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s10620-014-3093-7","article-title":"Factors affecting first-line triple therapy of H. pylori including","volume":"59","author":"Lee JY","year":"2014","journal-title":"Dig Dis Sci"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1128\/JCM.39.4.1319-1322.2001","article-title":"cagA status and eradication treatment outcome of anti-H. pylori triple therapies in patients with nonulcer dyspepsia","volume":"39","author":"Broutet N","year":"2001","journal-title":"J Clin Microbio l"},{"key":"ref332","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.gtc.2015.05.002","article-title":"Molecular approaches to identify H. pylori antimicrobial resistance","volume":"44","author":"M\u00e9graud F","year":"2015","journal-title":"Gastroenterol Clin North Am"},{"key":"ref333","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1128\/JCM.41.7.3336-3338.2003","article-title":"Comparison of genotyping H. pylori directly from biopsy specimens and genotyping from bacterial cultures","volume":"41","author":"Park CY","year":"2003","journal-title":"J Clin Microbio l"},{"key":"ref334","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1128\/JCM.41.10.4573-4577.2003","article-title":"Fast and accurate quantitative detection of H. pylori and identification of clarithromycin resistance mutations in H. pylori isolates from gastric biopsy specimens by real-time PCR","volume":"41","author":"Lascols C","year":"2003","journal-title":"J Clin Microbio l"},{"key":"ref335","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1128\/JCM.00744-09","article-title":"Evaluation of a new test, genotype HelicoDR, for molecular detection of antibiotic resistance in H. pylori","volume":"47","author":"Cambau E","year":"2009","journal-title":"J Clin Microbiol"},{"key":"ref336","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1590\/S0004-28032010000400011","article-title":"Clarithromycin-resistant H. pylori in Recife, Brazil, directly identified from gastric biopsies by polymerase chain reaction","volume":"47","author":"Lins AK","year":"2010","journal-title":"Arq Gastroenterol"},{"key":"ref337","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1590\/S0004-28032011000400008","article-title":"H. pylori antibiotic resistance in Brazil: clarithromycin is still a good option","volume":"48","author":"Eisig JN","year":"2011","journal-title":"Arq Gastroenterol"},{"key":"ref338","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/1471-230X-13-164","article-title":"Low H. pylori primary resistance to clarithromycin in gastric biopsy specimens from dyspeptic patients of a city in the interior of Sao Paulo, Brazil","volume":"13","author":"Suzuki RB","year":"2013","journal-title":"BMC Gastroenterol"},{"key":"ref339","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1590\/S0036-46652014000300003","article-title":"Resistance to amoxicillin, clarithromycin and ciprofloxacin of H. pylori isolated from Southern Brazil patients","volume":"56","author":"Picoli SU","year":"2014","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"ref340","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1590\/S0004-28032016000200012","article-title":"Molecular detection of clarithromycin and fluoroquinolones resistance in H. pylori infection, directly applied to gastric biopsies, in an urban Brazilian population","volume":"53","author":"Martins GM","year":"2016","journal-title":"Arq Gastroenterol"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"7587","DOI":"10.3748\/wjg.v22.i33.7587","article-title":"Detection of H. pylori resistance to clarithromycin and fluorquinolones in Brazil: A national survey","volume":"22","author":"Sanches BS","year":"2016","journal-title":"World J Gastroenterol"},{"key":"ref342","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/ajg.2014.24","article-title":"The problem of H. pylori resistance to antibiotics: a systematic review in Latin America","volume":"109","author":"Camargo MC","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"ref343","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3904\/kjim.2015.30.6.801","article-title":"Trends in H. pylori eradication rates by first-line triple therapy and related factors in eradication therapy","volume":"30","author":"Kim SE","year":"2015","journal-title":"Korean J Intern Med"},{"key":"ref344","doi-asserted-by":"crossref","first-page":"603\u20109","DOI":"10.1046\/j.1365-2036.2000.00744.x","article-title":"A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection","volume":"14","author":"Calvet X","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"ref345","doi-asserted-by":"crossref","first-page":"36B","DOI":"10.1155\/2003\/714124","article-title":"How can the current strategies for Helicobacter pylori eradication therapy be improved?","volume":"17","author":"Ford A","year":"2003","journal-title":"Can J Gastroenterol"},{"issue":"147","key":"ref346","doi-asserted-by":"crossref","first-page":"553","DOI":"10.7326\/0003-4819-147-8-200710160-00008","article-title":"Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication","volume":"3","author":"Fuccio L","year":"2007","journal-title":"Ann Intern Med"},{"key":"ref347","doi-asserted-by":"crossref","first-page":"S","DOI":"10.1016\/S0016-5085(10)61564-8","article-title":"Duration of proton-pump inhibitor-based triple therapy for Helicobacter pylori eradication: a meta-analysis","volume":"138","author":"Flores HB","year":"2010","journal-title":"Gastroenterology"},{"key":"ref348","article-title":"Optimum duration of regimens for H. pylori eradication","volume":"12","author":"Yuan Y","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"ref349","first-page":"407\u201012","article-title":"7, 10 and 14-days rabeprazole-based standard triple therapies for H. pylori eradication: are they still effective? A randomized trial","volume":"74","author":"Karatapanis S","year":"2011","journal-title":"Acta Gastroenterol Belg"},{"key":"ref350","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1523-5378.2009.00656.x","article-title":"Helicobacter pylori eradication therapy success regarding different treatment period based on clarithromycin or metronidazole triple-therapy regimens","volume":"14","author":"Filipec Kanizaj T","year":"2009","journal-title":"Helicobacter"},{"key":"ref351","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5061640","article-title":"Efficacy of 7-Day and 14-Day Triple Therapy Regimens for the Eradication of H. pylori: A Comparative Study in a Cohort of Romanian Patients","volume":"2016","author":"Arama SS","year":"2016","journal-title":"Gastroenterol Res Pract"},{"key":"ref352","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1093\/jac\/dkw220","article-title":"Systematic review and meta-analysis: triple therapy combining a proton-pump inhibitor, amoxicillin and metronidazole for H. pylori first-line treatment","volume":"71","author":"Puig I","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"ref353","doi-asserted-by":"crossref","first-page":"51\u201069","DOI":"10.1053\/j.gastro.2016.04.006","article-title":"The Toronto Consensus for the treatment of Helicobacter pylori infection in adults","volume":"151","author":"Fallone CA","year":"2016","journal-title":"Gastroenterology"},{"key":"ref354","series-title":"ACG Clinical Guideline: treatment of Helicobacter pylori infection","first-page":"212","volume":"112","author":"Chey WG","year":"2017"},{"key":"ref355","first-page":"1134","article-title":"Bismuth-containing quadruple therapy for Helicobacter pylori: lessons from China","volume":"25","author":"Lu H","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref356","doi-asserted-by":"crossref","first-page":"382\u201090","DOI":"10.1111\/j.1523-5378.2012.00962.x","article-title":"Greater than 95% success with 14-day bismuth quadruple anti-Helicobacter pylori therapy: a pilot study in US Hispanics","volume":"17","author":"Salazar CO","year":"2012","journal-title":"Helicobacter"},{"key":"ref357","doi-asserted-by":"crossref","first-page":"79\u201088","DOI":"10.1038\/nrgastro.2010.210","article-title":"Optimal therapy for Helicobacter pylori infections","volume":"8","author":"Rimbara E","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref358","first-page":"478\u201085","article-title":"Efficacy of 7-day and 14-day bismuth-containing quadruple therapy and 7-day and 14-day moxifloxacin-based triple therapy as second-line eradication for Helicobacter pylori infection","volume":"9","author":"Lee ST","year":"2015","journal-title":"Gut Liv"},{"key":"ref359","first-page":"131\u20105","article-title":"Comparison of the effectiveness of quadruple salvage regimen for Helicobacter pylori infection according to the duration of treatment","volume":"47","author":"Choung RS","year":"2006","journal-title":"Korean J Gastroenterol"},{"key":"ref360","first-page":"38\u201045","article-title":"Bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate in Korea","volume":"15","author":"Lee BH","year":"2010","journal-title":"Helicobacter"},{"key":"ref361","first-page":"136\u201041","article-title":"Efficacy of 14 day OBMT therapy as a second-line treatment for Helicobacter pylori infection","volume":"44","author":"Park SC","year":"2004","journal-title":"Korean J Gastroenterol"},{"key":"ref362","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0140-6736(11)60020-2","article-title":"Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial","volume":"377","author":"Malfertheiner P","year":"2011","journal-title":"Lancet"},{"key":"ref363","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/apt.12808","article-title":"Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication of Helicobacter pylori","volume":"40","author":"Delchier JC","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"ref364","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12429","article-title":"Efficacy of three-in-one capsule bismuth quadruple therapy for Helicobacter pylori eradication in clinical practice in a multinational patient population","volume":"22","author":"Miehlke S","year":"2017","journal-title":"Helicobacter"},{"key":"ref365","first-page":"11","article-title":"Non-bismuth quadruple concomitant therapies in the eradication of Helicobacter pylori: standard vs. optimized (14 days, high-dose PPI) regimens in clinical practice","volume":"19","author":"McNicholl A","year":"2014","journal-title":"Helicobacter"},{"key":"ref366","doi-asserted-by":"crossref","first-page":"581\u20109","DOI":"10.1111\/apt.13069","article-title":"Optimized empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study","volume":"41","author":"Molina-Infante J","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"ref367","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/jgh.13510","article-title":"Randomized clinical trial comparing 10- or 14-day sequential therapy and 10- or 14-day concomitant therapy for the first line empirical treatment of H. pylori infection","volume":"32","author":"Park SM","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"ref368","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/MEG.0000000000000590","article-title":"Randomized clinical trial comparing 10-day sequential, 7-day concomitant and 7-day standard triple therapies for H. pylori eradication","volume":"28","author":"Tepe\u0161 B","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref369","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1136\/gutjnl-2015-310142","article-title":"Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of H. pylori in the community and hospital populations: a randomised trial","volume":"65","author":"Liou JM","year":"2016","journal-title":"Gut"},{"key":"ref370","doi-asserted-by":"crossref","first-page":"102","DOI":"10.22192\/ijcrms.2017.03.03.013","article-title":"To compare efficacy of 10-day sequential triple therapy versus 14-days sequential therapy for the eradication of H. pylori","volume":"3","author":"Charan S","year":"2017","journal-title":"Int J Curr Res Med Sci"},{"key":"ref371","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/apt.13495","article-title":"Systematic review with meta-analysis: 10- or 14-day sequential therapy vs. 14-day triple therapy in the first line treatment of H. pylori infection","volume":"43","author":"Liou JM","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"ref372","article-title":"Efficacy of H. pylori eradication therapies in Korea: A systematic review and network meta-analysis","volume":"22","author":"Jung YS","year":"2017","journal-title":"Helicobacter"},{"key":"ref373","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s002280050013","article-title":"Continued use of the proton-pump inhibitor lansoprazole following Helicobacter pylori eradication","volume":"55","author":"Claessens AA","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"ref374","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1365-2036.2005.02418.x","article-title":"Systematic review and meta-analysis: is 1-week proton pump inhibitor-based triple therapy sufficient to heal peptic ulcer?","volume":"21","author":"Gisbert JP","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"ref375","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2036.2003.01402.x","article-title":"Is eradication sufficient to heal gastric ulcers in patients infected with Helicobacter pylori? A randomized, controlled, prospective study","volume":"17","author":"Higuchi K","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"ref376","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/ajg.2012.132","article-title":"Long-term follow-up of 1,000 patients cured of Helicobacter pylori infection following an episode of peptic ulcer bleeding","volume":"107","author":"Gisbert JP","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"ref377","article-title":"Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people","volume":"4","author":"Ford AC","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"ref378","doi-asserted-by":"crossref","first-page":"6400","DOI":"10.3748\/wjg.v20.i21.6400","article-title":"Efficacy of tailored Helicobacter pylori eradication therapy based on antibiotic susceptibility and CYP2C19 genotype","volume":"20","author":"Sugimoto M","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref379","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1365-2036.2008.03807.x","article-title":"Meta-analysis: high-dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication","volume":"28","author":"Villoria A","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"ref380","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1365-2036.2012.05211.x","article-title":"Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection","volume":"36","author":"McNicholl AG","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"ref381","article-title":"Effects of CYP2C19 loss-of-function variants on the eradication of H. pylori infection in patients treated with proton pump inhibitor-based triple therapy regimens: a meta-analysis of randomized clinical trials","volume":"8","author":"Tang HL","year":"2013","journal-title":"PLoS One"},{"key":"ref382","series-title":"Desenvolvimento de metodologia para a determina\u00e7\u00e3o dos gen\u00f3tipos principais dos genes CYP2D6, CYP2C19 e CYP2C9: aplica\u00e7\u00e3o na farmacologia","author":"Prado Carolina Martins do","year":"2010"},{"key":"ref383","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/tpj.2010.89","article-title":"Global pharmacogenomics: Impact of population diversity on the distribution of polymorphisms in the CYP2C cluster among Brazilians","volume":"12","author":"Suarez-Kurtz G","year":"2012","journal-title":"Pharmacogenomics J"},{"key":"ref384","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s11033-013-2990-8","article-title":"Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians","volume":"41","author":"Kohlrausch FB","year":"2014","journal-title":"Mol Biol Rep"},{"issue":"3","key":"ref385","doi-asserted-by":"crossref","DOI":"10.4238\/gmr.15038734","article-title":"Influence of CYP2C19 on Helicobacter pylori eradication in Brazilian patients with functional dyspepsia","volume":"15","author":"Nabinger DD","year":"2016","journal-title":"Genet Mol Res"},{"key":"ref386","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/j.gastro.2013.03.050","article-title":"Optimized nonbismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistance","volume":"145","author":"Molina-Infante J","year":"2013","journal-title":"Gastroenterology"},{"key":"ref387","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/00365521.2015.1079646","article-title":"Concomitant versus sequential therapy for the treatment of Helicobacter pylori infection: a Greek randomized prospective study","volume":"51","author":"Apostolopoulos P","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"ref388","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1099\/jmm.0.072322-0","article-title":"Sequential, concomitant and hybrid first-line therapies for Helicobacter pylori eradication: a prospective randomized study","volume":"63","author":"De Francesco V","year":"2014","journal-title":"J Med Microbiol"},{"key":"ref389","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1136\/gutjnl-2015-309900","article-title":"Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy","volume":"64","author":"Zhang W","year":"2015","journal-title":"Gut"},{"key":"ref390","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f4587","article-title":"Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy","volume":"347","author":"Gatta L","year":"2013","journal-title":"BMJ"},{"key":"ref391","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/818043","article-title":"Standard Triple Therapy versus Sequential Therapy in Helicobacter pylori Eradication: A Double-Blind, Randomized, and Controlled Trial","volume":"2015","author":"Eisig JN","year":"2015","journal-title":"Gastroenterol Res Pract"},{"key":"ref392","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1517\/14656566.2013.782286","article-title":"A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication)","volume":"14","author":"Marin AC","year":"2013","journal-title":"Expert Opin Pharmacother"},{"issue":"1S","key":"ref393","first-page":"A5","article-title":"The efficacy of second-line anti-Helicobacter pylori eradication using 10-day and 14-day levofloxacin-containing triple therapy","volume":"1","author":"Tai WC","year":"2013","journal-title":"United European Gastroenterology Journal"},{"key":"ref394","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.dld.2008.09.013","article-title":"Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication","volume":"41","author":"Di Caro S","year":"2009","journal-title":"Dig Liver Dis"},{"key":"ref395","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.gtc.2010.08.007","article-title":"Pharmacologic aspects of eradication therapy for Helicobacter pylori Infection","volume":"39","author":"Furuta T","year":"2010","journal-title":"Gastroenterol Clin North Am"},{"key":"ref396","first-page":"131","article-title":"Second-line and rescue therapies for Helicobacter pylori eradication in clinical practice","volume":"19","author":"Zullo A","year":"2010","journal-title":"J Gastrointestin Liver Dis"},{"key":"ref397","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2036.2006.02764.x","article-title":"Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection","volume":"23","author":"Wong WM","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"ref398","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/apt.13128","article-title":"Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments","volume":"41","author":"Gisbert JP","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"ref399","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/1751-2980.12498","article-title":"Comparison of 10-day levofloxacin bismuth-based quadruple therapy and levofloxacin-based triple therapy for Helicobacter pylori","volume":"18","author":"Wu TS","year":"2017","journal-title":"J Dig Dis"},{"key":"ref400","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2036.2011.04937.x","article-title":"Review article: rifabutin in the treatment of refractory Helicobacter pylori infection","volume":"35","author":"Gisbert JP","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"ref401","article-title":"Rescue Therapy with a Proton Pump Inhibitor Plus Amoxicillin and Rifabutin for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis","volume":"2015","author":"Liu X","year":"2015","journal-title":"Gastroenterol Res Pract"},{"key":"ref402","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1365-2036.2012.05053.x","article-title":"Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylorieradication failures","volume":"35","author":"Gisbert JP","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"ref403","article-title":"Vonoprazan improves the efficacy of Helicobacter pylori eradication therapy with a regimen consisting of clarithromycin and metronidazole in patients allergic to penicillin","volume":"00","author":"Ono S","year":"2017","journal-title":"Helicobacter"},{"key":"ref404","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s11882-014-0476-y","article-title":"Penicillin and beta-lactam allergy: Epidemiology and diagnosis","volume":"14","author":"Macy E","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"key":"ref405","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s10620-014-3365-2","article-title":"Helicobacter pylori first\u2010line and rescue treatments in the presence of penicillin allergy","volume":"60","author":"Gisbert JP","year":"2015","journal-title":"Dig Dis Sci"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/ag\/v55n2\/1678-4219-ag-s0004-2803-20180000020.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T13:39:51Z","timestamp":1751549991000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032018000200097&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,16]]},"references-count":405,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,6]]}},"alternative-id":["S0004-28032018000200097"],"URL":"https:\/\/doi.org\/10.1590\/s0004-2803.201800000-20","relation":{},"ISSN":["1678-4219","0004-2803"],"issn-type":[{"value":"1678-4219","type":"electronic"},{"value":"0004-2803","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4,16]]}}}